Senior Director Cell Therapy Strategy & Portfolio Leader

Bristol Myers Squibb; Princeton (NJ); On-site; USD 221,000 - 268,000; Full time

Benefits offered by this job

Flexible Time Off

11 paid holidays

Competitive benefits

Job summary

Bristol Myers Squibb in New Jersey seeks a Senior Director, Cell Therapy Product Leader to own end-to-end product strategy and drive long-range plans for the Cell Therapy portfolio. You will align strategies with development, manufacturing, and supply chain leaders to optimize performance and patient impact.

You will chair cross-functional GO Teams, translate strategies into integrated supply, network and technology roadmaps, and ensure delivery of LTFP commitments while advancing commercial and

Qualifications

• Progressive leadership experience across biotech, pharma, or related functions.
• Experience leading cross-functional product, portfolio, or business initiatives.
• Deep understanding of cell therapy or biologics value chains.

Responsibilities

• Own end-to-end product strategy for assigned CT assets and brands.
• Translate strategy into integrated supply, network, capacity, and tech plans.
• Chair GO Teams and govern the product Book of Work.
• Lead matrix across Development, MSAT, Manufacturing, Supply Chain, Quality, Finance.
• Develop multi-year roadmaps aligned to KPIs and LTFP commitments.

Skills

Leadership

Cross-functional leadership

Strategic planning

Communication skills

Education

Bachelor's degree in science/engineering

Master's degree preferred

Job description

Bristol Myers Squibb in New Jersey seeks a Senior Director, Cell Therapy Product Leader to own end-to-end product strategy and drive long-range plans for the Cell Therapy portfolio. You will align strategies with development, manufacturing, and supply chain leaders to optimize performance and patient impact.

You will chair cross-functional GO Teams, translate strategies into integrated supply, network and technology roadmaps, and ensure delivery of LTFP commitments while advancing commercial and